HelgelandA. Treatment of mild hypertension. A five year controlled drug trial. The Oslo study. Am J Med1980; 69: 725–32.
2.
Report by the management committee. The Australian therapeutic trial in mild hypertension. Lancet1980; 2: 1261–67.
3.
WiserTH. Essential hypertension. In: KatcherBSYoungLYKoda-KimbleMA, eds. Applied therapeutics; the clinical use of drugs. Spokane, WA: Applied Therapeutics, 1983:117–50.
4.
ColucciWSBraunwaldE. Adrenergic receptors: New concepts and implications for cardiovascular therapeutics. In: ContiCR, ed. Cardiac drug therapy. Philadelphia: FA Davis, 1984:39–60.
5.
LowenthalDT. The clinical pharmacology of beta-adrenergic blockers. In: ContiCR, ed. Cardiac drug therapy. Philadelphia: FA Davis, 1984:61–72.
6.
FrohlichED. Clinical considerations in the patient requiring multidrug management of hypertension. Pract Cardiol1982; 8 (5): 59–71.
7.
SullivanJM. Physiologic and biochemical profile for rational clinical management. Adv Intern Med1978; 23: 219–49.
8.
MatersonBJFriesED. VA cooperative study group: Propranolol vs. hydrochlorothiazide as monotherapy for mild to moderate hypertension. Circulation1981; 64 (suppl IV): 323.
9.
WeberMADrayerJIM. The impact of antihypertensives on cardiovascular risks. Drug Ther Hosp1983; Apr: 119–24.
10.
LowensteinJNeusyAJ. The biochemical effects of antihypertensive agents and the impact of atherosclerosis. J Cardiovasc Pharmacol1981; 3 (suppl 3): S256–60.
11.
AmesRP. Negative effects of diuretic drugs on metabolic risk factors for coronary heart disease: Possible alternative therapies. Am J Cardiol1983; 51: 632–8.
12.
AmesRPHillP. Antihypertensive therapy and the risk of coronary heart disease. J Cardiovasc Pharmacol1982; 4: S206–12.
13.
RyanMPRyanMFCauhihanTB. The effect of diuretics on lymphocyte magnesium and potassium. Acta Med Scand [Suppl] 1981; 647: S153–61.
14.
WhangROciTOAikawaJKMagnesium and potassium interrelationships experimental and clinical. Acta Med Scand1981;Suppl 647:S139–44.
15.
HollifiedJWSlatonPE. Thiazide diuretics hypokalemia and cardiac arrhythmias. Acta Med Scand1981;suppl 647:S67–73.
16.
WesterPODychknerT. Diuretic treatment and magnesium loss. Acta Med Scand1981;suppl 647:S145–52.
17.
GilmanAGGoodmanLSRallTWMuradF, eds. Goodman and Gilman's the pharmacological basis of therapeutics. 7th ed.New York: Macmillan, 1985:784–805.
18.
ThadaniU. Beta blockers in hypertension. Am J Cardiol1983; 52: 10d–5d.
19.
WeberMADrayerJIM. Antihypertension agents that act in the central nervous system. Cardiovasc Rev Rep1982; 3 (2): 255–70.
20.
ColluciWS. Alpha-adrenergic receptor blockade with prazosin. Ann Intern Med1982; 97: 67–77.
21.
PopliSDaugirdasJTNeubauerJAHockenberryBHanoJEIngTS. Transdermal clonidine in mild hypertension: A randomized, double-blind, placebo-controlled trial. Arch Intern Med1986; 146: 2140–4.
22.
FrohlichED. Mechanism contributing to high blood pressure. Ann Intern Med1983; 98 (part 2): 709–14.
23.
MullerFBBolliPErnePKiowskiWBuhlerFR. Use of calcium antagonists as monotherapy in the management of hypertension. Am J Med1984; 77 (2B): 11–5.
24.
EdmondsonRPSMacGregorGA. Leukocyte cation transport in essential hypertension: Its relation to the renin angiotensin system. Br Med J1981; 282: 1267–9.
25.
GuytonACColemanTGCowleyAWArterial pressure regulation: Overriding dominance of the kidneys in long term regulation and in hypertension. Am J Med1972; 52: 584–91.
26.
TaraziRF. Pathophysiology of essential hypertension. Am J Med1983; 75 (suppl): 2–8.